Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12614000008628
Ethics application status
Approved
Date submitted
10/12/2013
Date registered
3/01/2014
Date last updated
25/09/2014
Type of registration
Prospectively registered
Titles & IDs
Public title
A double-blind, randomised, placebo-controlled study to evaluate the effectiveness of an orally dosed supplement, Skin Accumax, containing vitamin A, vitamin E, vitamin C, phosphatidylcholine (lecithin) and diindolylmethane, on treating acne in men and women aged between 16 and 35.
Query!
Scientific title
A double-blind, randomised, placebo-controlled study to evaluate the effectiveness of an orally dosed supplement, Skin Accumax, containing vitamin A, vitamin E, vitamin C, phosphatidylcholine (lecithin) and diindolylmethane, on treating acne in men and women aged between 16 and 35.
Query!
Secondary ID [1]
283467
0
nil
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Acne
290381
0
Query!
Condition category
Condition code
Skin
290772
290772
0
0
Query!
Dermatological conditions
Query!
Alternative and Complementary Medicine
291124
291124
0
0
Query!
Other alternative and complementary medicine
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
The intervention is an orally dose nutritional supplement called Skin Accumax. The active ingredients in the supplement are Vitamin A (200ug), Vitamin E (19.6mg alpha tocopherol), Vitamin C (40mg), Phosphatidylcholine (75mg) and Diindolylmethane (18mg).
The daily dose will be 4 capsules per day; 2 capsules with breakfast and 2 capsules with the evening meal.
The duration of treatment is 16 weeks.
Strategies used to monitor adherence include monitoring through fortnightly follow-up, email contact, return of used medication at completion of study.
Query!
Intervention code [1]
288176
0
Treatment: Other
Query!
Comparator / control treatment
Capsules containing maltodextrin identical in size and shape of the active.
Query!
Control group
Placebo
Query!
Outcomes
Primary outcome [1]
290771
0
Assess the effectiveness of the orally dosed nutritional supplement, Skin Accumax, on treatment of persistent acne grade II and III in men and women aged 16-35 over 16 weeks.
The reduction in severity of acne will be assessed using photography before, during and at completion of treatment (and results assessed by a dermatologist).
Query!
Assessment method [1]
290771
0
Query!
Timepoint [1]
290771
0
Baseline, 8 weeks and 16 weeks
Query!
Secondary outcome [1]
305247
0
Assess quality of life and self-esteem before (baseline) and after treatment with Skin Accumax using a QOL questionnaire, administered before, during and at completion of treatment.
Query!
Assessment method [1]
305247
0
Query!
Timepoint [1]
305247
0
Baseline, 8 weeks and 16 weeks
Query!
Secondary outcome [2]
306014
0
Evaluate dietary influences on acne through a 3 day food diary to be filled out at completion of treatment (week 16).
Query!
Assessment method [2]
306014
0
Query!
Timepoint [2]
306014
0
At 16 weeks only
Query!
Eligibility
Key inclusion criteria
Males and females
Aged between 16 and 35
Have persistent acne grade II and III
Currently using standard anti-microbial washes as the skin treatment only
Otherwise healthy
Written informed consent from the subject and/or guardians (under 18 years)
Query!
Minimum age
16
Years
Query!
Query!
Maximum age
35
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Any condition which in the opinion of the investigator makes the subject unsuitable for inclusion
Males or females receiving treatment for acne (including corticosteroids, estrogens, progesterone) within the last month
Females currently on the contraceptive pill, pregnant or breastfeeding
Any person currently on anti-coagulant therapy.
Participation in any other clinical trial during last 30 days
Simultaneous participation in another clinical trial
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
The potential participants are screened by the medical monitor for inclusion in the study.
The eligible participants are enrolled by Investigator and provided with a "Numbered Container" that is identical to all other containers and contains the same information on the label, except for the number. The investigator is blinded to the product randomized with the numbered containers labelled prior to delivery to Investigation Site.
Product allocated as participants are enrolled in sequential order (1-80).
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Computer randomized software
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people receiving the treatment/s
The people administering the treatment/s
The people assessing the outcomes
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 3 / Phase 4
Query!
Type of endpoint/s
Safety/efficacy
Query!
Statistical methods / analysis
The sample size required to assess a 30% reduction on acne severity, based on an 80% confidence, is 30 participants in each arm, total of 60 participants.
The primary endpoint is reduction in Acne Severity (assessed at baseline, week 8 and week 16). The severity is defined as the severity of acne and the percentage of the face and neck affected. The mean percentage change in area will be calculated. Data will be analysed using SPSS statistical software to test for equality of means between the active and placebo groups at each time point.
QOL questionnaires will be analysed using SPSS statistical software for difference in mean values between the active and placebo group at each time point. The specific statistical test will be determined once the initial data has been analysed for normality.
Query!
Recruitment
Recruitment status
Recruiting
Query!
Date of first participant enrolment
Anticipated
3/02/2014
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
80
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
QLD
Query!
Recruitment postcode(s) [1]
7499
0
4005 - New Farm
Query!
Funding & Sponsors
Funding source category [1]
288173
0
Commercial sector/Industry
Query!
Name [1]
288173
0
International Institute for Anti-aging (IIAA)
Query!
Address [1]
288173
0
12 Priestley Way
London
NW2 7AP
Query!
Country [1]
288173
0
United Kingdom
Query!
Primary sponsor type
Commercial sector/Industry
Query!
Name
Integrated Health Group Pty. Ltd.
Query!
Address
Integrated Health Group Pty. Ltd.
362 Water Street Fortitude Valley
Brisbane QLD 4002
Query!
Country
Australia
Query!
Secondary sponsor category [1]
286897
0
None
Query!
Name [1]
286897
0
Query!
Address [1]
286897
0
Query!
Country [1]
286897
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
290086
0
Queensland Clinical Trial Network
Query!
Ethics committee address [1]
290086
0
Level 3, 88 Jephson Street Toowong, QLD, 4066
Query!
Ethics committee country [1]
290086
0
Australia
Query!
Date submitted for ethics approval [1]
290086
0
Query!
Approval date [1]
290086
0
18/11/2013
Query!
Ethics approval number [1]
290086
0
Query!
Summary
Brief summary
This is a single-site, double-blind, randomised, clinical trial of 16 weeks duration and utilising active and placebo arms with baseline data collection. The study aims to: Assess the effectiveness of orally dosed supplement Skin Accumax on treatment of persistent acne grade II and lll in men and women aged 16 to 35, over 16 weeks. Assess quality of life and self-esteem before and after treatment. Evaluate dietary influences on acne through dietary survey. Evaluate safety and tolerability over 16 weeks. Provide information that will be required by Therapeutic Goods Administration (TGA) and international regulatory bodies to support product tolerability and therapeutic claims.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
43894
0
Dr Elizabeth Steels
Query!
Address
43894
0
Integrated Health Group Pty. Ltd. 362 Water Street Fortitude Valley Brisbane
4002 QLD
Query!
Country
43894
0
Australia
Query!
Phone
43894
0
+61 7 31620909
Query!
Fax
43894
0
Query!
Email
43894
0
[email protected]
Query!
Contact person for public queries
Name
43895
0
Elizabeth Steels
Query!
Address
43895
0
Integrated Health Group Pty. Ltd. P.O. Box 68 New Farm Brisbane 4005 QLD
Query!
Country
43895
0
Australia
Query!
Phone
43895
0
+61 7 31620909
Query!
Fax
43895
0
Query!
Email
43895
0
[email protected]
Query!
Contact person for scientific queries
Name
43896
0
Elizabeth Steels
Query!
Address
43896
0
Integrated Health Group Pty. Ltd. P.O. Box 68 New Farm Brisbane 4005 QLD
Query!
Country
43896
0
Australia
Query!
Phone
43896
0
+61 7 31620909
Query!
Fax
43896
0
Query!
Email
43896
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF